Tag: Amycretin

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Amycretin

Metsera: $290 Million Secured To Develop Medicines For Obesity And Metabolic Diseases

Added to Collection on: 2024-04-21 00:27:43

Tags for this article:

Peptide hormones
Anti-diabetic drugs
GLP-1 receptor agonist
Glucagon-like peptide-1
PEPTIDE THERAPEUTICS
Incretin
Diabetes medication
Amycretin

Click the tags to see associated articles and topics

View Article Details
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You? | The Motley Fool

Added to Collection on: 2024-05-12 17:26:18

Tags for this article:

Cyclopropanes
Fluoroarenes
Quinolines
Infectious causes of cancer
Novo Nordisk
Semaglutide
Exelixis
Cabozantinib
Amycretin
Zanzalintinib
Protein kinase inhibitor
Obesity

Click the tags to see associated articles and topics

View Article Details
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped

Added to Collection on: 2024-07-17 19:49:31

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
GLP-1 receptor agonist
Semaglutide
Novo Nordisk
Pharmaceutical industry in China
Eli Lilly and Company
Tirzepatide
Pharmaceutical industry
Anti-obesity medication
Stock market
Amycretin
Roche AG

Click the tags to see associated articles and topics

View Article Details
Roche Is Raising The Efficacy Bar For The Oral GLP-1 Drug Class - Seeking Alpha

Added to Collection on: 2024-07-22 19:00:30

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
CT-388
Anti-obesity medication
Amycretin
GLP-1 receptor agonist
Semaglutide
GSBR-1290
Glucagon-like peptide-1
VK2735
Tirzepatide
GLP1 poly-agonist peptides

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk to present more obesity data in the year's second half - MedWatch

Added to Collection on: 2024-08-08 19:04:18

Tags for this article:

PEPTIDE THERAPEUTICS
In Denmark
In science
Semaglutide
Novo Nordisk
Cagrilintide/semaglutide
Anti-obesity medication
Management of obesity
Nordisk
NNE
Amycretin

Click the tags to see associated articles and topics

View Article Details
Deep Dive: Obesity and Diabetes Markets Explode - BioSpace

Added to Collection on: 2024-09-24 19:02:40

Tags for this article:

Peptide hormones
PEPTIDE THERAPEUTICS
Research and development in the United States
GLP-1 receptor agonist
Novo Nordisk
Semaglutide
Amycretin
Anti-obesity medication
Eli Lilly and Company
Glucagon-like peptide-1
Liraglutide
Tirzepatide
GLP-1

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk: Undervalued Pharma Heavyweight With Upside Potential - AInvest

Added to Collection on: 2025-08-24 14:42:34

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Peptide hormones
Novo Nordisk
Anti-diabetic drugs
Semaglutide
Eli Lilly and Company
Cagrilintide/semaglutide
Glucagon-like peptide-1
Catalent
Eli Lilly
Amycretin

Click the tags to see associated articles and topics

View Article Details
Book a Demo